Harvard Bioscience (HBIO) Revenue Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.19 Bn | 120.97 Bn | 1.96 Bn | 18.10% |
| 2 | Becton Dickinson | 44.76 Bn | 43.95 Bn | 2.15 Bn | -0.75% |
| 3 | Alcon | 32.93 Bn | 31.28 Bn | 1.53 Bn | 4.80% |
| 4 | Medline | 32.80 Bn | 30.56 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.51 Bn | 27.85 Bn | 890.98 Mn | 8.62% |
| 6 | West Pharmaceutical Services | 23.59 Bn | 23.15 Bn | 329.20 Mn | 4.99% |
| 7 | Solventum | 14.01 Bn | 13.45 Bn | 1.10 Bn | -0.07% |
| 8 | Cooper Companies | 13.77 Bn | 13.63 Bn | 735.40 Mn | 7.22% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 3.32% |
| 10 | Harvard Bioscience | 26.75 Mn | 19.65 Mn | 12.24 Mn | -11.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.53% |
| Dec 31, 2025 | -5.84% |
| Sep 30, 2025 | -8.55% |
| Jun 30, 2025 | -11.20% |
| Mar 31, 2025 | -8.88% |
| Dec 31, 2024 | -9.43% |
| Sep 30, 2024 | -9.52% |
| Jun 30, 2024 | -7.51% |
| Mar 31, 2024 | -3.16% |
| Dec 31, 2023 | -3.14% |
| Sep 30, 2023 | 1.81% |
| Jun 30, 2023 | 7.26% |
| Mar 31, 2023 | 8.04% |
| Dec 31, 2022 | -2.82% |
| Sep 30, 2022 | -0.61% |
| Jun 30, 2022 | -0.43% |
| Mar 31, 2022 | 0.68% |
| Dec 31, 2021 | -0.80% |
| Sep 30, 2021 | 1.18% |
| Jun 30, 2021 | -2.52% |